Literature DB >> 17045970

Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats.

Gregory P Mark1, Anthony E Kinney, Michele C Grubb, Xiaoman Zhu, Deborah A Finn, Sarah L Mader, S Paul Berger, Anita J Bechtholt.   

Abstract

Mesencephalic dopamine neurons form synapses with acetylcholine (ACh)-containing interneurons in the nucleus accumbens (NAcc). Although their involvement in drug reward has not been systematically investigated, these large aspiny interneurons may serve an important integrative function. We previously found that repeated activation of nicotinic cholinergic receptors enhanced cocaine intake in rats but the role of muscarinic receptors in drug reward is less clear. Here we examined the impact of local changes in muscarinic receptor activation within the NAcc on cocaine and food self-administration in rats trained on a progressive ratio (PR) schedule of reinforcement. Animals were given a minimum of 9 continuous days of drug access before testing in order to establish a stable breaking point (BP) for intravenous cocaine infusions (0.75 mg/kg/infusion). Rats in the food group acquired stable responding on the PR schedule within 7 days. On the test day, rats were bilaterally infused in the NAcc with the muscarinic receptor agonist oxotremorine methiodide (OXO: 0.1, 0.3 or 1 nmol/side), OXO plus the M(1) selective antagonist pirenzepine (PIRENZ; 0.3 nmol/side) or aCSF 15 min before cocaine or food access. OXO dose dependently reduced BP values for cocaine reinforcement (-17%, -44% [p<0.05] and -91% [p<0.0001] for 0.1, 0.3 and 1.0 nmol, respectively) and these reductions dissipated by the following session. Pretreatment with PIRENZ blocked the BP-reducing effect of 0.3 nmol OXO. Notably, OXO (0.1, 0.3 and 1.0 nmol/side) injection in the NAcc did not affect BP for food reward. The results suggest that muscarinic ACh receptors in the caudomedial NAcc may play a role in mediating the behavior reinforcing effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045970      PMCID: PMC1762000          DOI: 10.1016/j.brainres.2006.09.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  Posttraining intra-basolateral amygdala scopolamine impairs food- and amphetamine-induced conditioned place preferences.

Authors:  Jason P Schroeder; Mark G Packard
Journal:  Behav Neurosci       Date:  2002-10       Impact factor: 1.912

2.  Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine.

Authors:  M L Berlanga; C M Olsen; V Chen; A Ikegami; B E Herring; C L Duvauchelle; A A Alcantara
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 3.  Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands.

Authors:  Joshua M Gulley; Nancy R Zahniser
Journal:  Eur J Pharmacol       Date:  2003-10-31       Impact factor: 4.432

4.  Muscarinic receptor antagonism in the basolateral amygdala blocks acquisition of cocaine-stimulus association in a model of relapse to cocaine-seeking behavior in rats.

Authors:  R E See; J McLaughlin; R A Fuchs
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

5.  Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats.

Authors:  A D Lê; A Wang; S Harding; W Juzytsch; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2003-01-21       Impact factor: 4.530

6.  Alteration in behavioral sensitivity to amphetamine after treatment with oxotremorine. Effect of dose and test environment.

Authors:  Sławomir Gralewicz; Piotr Lutz; Dorota Wiaderna; Tadeusz Tomas
Journal:  Behav Brain Res       Date:  2003-12-17       Impact factor: 3.332

Review 7.  Involvement of cholinergic neuronal systems in intravenous cocaine self-administration.

Authors:  James E Smith; Conchita Co; Xinhe Yin; Glen M Sizemore; Anthony Liguori; Walter E Johnson; Thomas J Martin
Journal:  Neurosci Biobehav Rev       Date:  2004-01       Impact factor: 8.989

8.  Role for M5 muscarinic acetylcholine receptors in cocaine addiction.

Authors:  Anders Fink-Jensen; Irina Fedorova; Gitta Wörtwein; David P D Woldbye; Thøger Rasmussen; Morgane Thomsen; Tom G Bolwig; Karen M Knitowski; David L McKinzie; Masahisa Yamada; Jürgen Wess; Anthony Basile
Journal:  J Neurosci Res       Date:  2003-10-01       Impact factor: 4.164

Review 9.  Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction.

Authors:  Huibert D Mansvelder; Mischa De Rover; Daniel S McGehee; Arjen B Brussaard
Journal:  Eur J Pharmacol       Date:  2003-11-07       Impact factor: 4.432

10.  Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors.

Authors:  D S Macêdo; E E Correia; S M M Vasconcelos; L M V Aguiar; G S B Viana; F C F Sousa
Journal:  Cell Mol Neurobiol       Date:  2004-02       Impact factor: 5.046

View more
  18 in total

1.  Adenosine A2A receptors in the nucleus accumbens bi-directionally alter cocaine seeking in rats.

Authors:  Casey E O'Neill; McKenzie L LeTendre; Ryan K Bachtell
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Effects of dopamine D1-like and D2-like antagonists on cocaine discrimination in muscarinic receptor knockout mice.

Authors:  Morgane Thomsen; Simon Barak Caine
Journal:  Eur J Pharmacol       Date:  2016-02-11       Impact factor: 4.432

3.  Acute and chronic effects of the M1/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats.

Authors:  Morgane Thomsen; Brian S Fulton; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2013-08-31       Impact factor: 4.530

4.  Muscarinic acetylcholine receptors in the nucleus accumbens core and shell contribute to cocaine priming-induced reinstatement of drug seeking.

Authors:  Judy Yee; Katie R Famous; Thomas J Hopkins; Michael C McMullen; R Christopher Pierce; Heath D Schmidt
Journal:  Eur J Pharmacol       Date:  2010-10-27       Impact factor: 4.432

Review 5.  Cholinergic functioning in stimulant addiction: implications for medications development.

Authors:  Mehmet Sofuoglu; Marc Mooney
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

6.  Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.

Authors:  Lauren Joseph; Morgane Thomsen
Journal:  Behav Brain Res       Date:  2017-04-22       Impact factor: 3.332

7.  Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway.

Authors:  Lauren K Dobbs; Gregory P Mark
Journal:  Behav Brain Res       Date:  2011-09-17       Impact factor: 3.332

8.  Linking Cholinergic Interneurons, Synaptic Plasticity, and Behavior during the Extinction of a Cocaine-Context Association.

Authors:  Junuk Lee; Joel Finkelstein; Jung Yoon Choi; Ilana B Witten
Journal:  Neuron       Date:  2016-05-19       Impact factor: 17.173

9.  Natural addiction: a behavioral and circuit model based on sugar addiction in rats.

Authors:  Bartley G Hoebel; Nicole M Avena; Miriam E Bocarsly; Pedro Rada
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

Review 10.  Accumbens dopamine-acetylcholine balance in approach and avoidance.

Authors:  Bartley G Hoebel; Nicole M Avena; Pedro Rada
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.